Sean P. Cregan
London, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
ATF4 activates a transcriptional program that chronically suppresses mTOR activity and promotes neurodegeneration in Parkinson disease models.
Journal: Cell reports
Published: July 14, 2025
The Ethanolic Extract of Polygala paniculata L. Blocks Panx1 Channels and Reduces Ischemic Brain Infarct in a Dose- and Sex-Dependent Way.
Journal: Molecular neurobiology
Published: May 27, 2024
Activating transcription factor-4 promotes neuronal death induced by Parkinson's disease neurotoxins and α-synuclein aggregates.
Journal: Cell death and differentiation
Published: November 25, 2019
Autocrine GABA signaling distinctively regulates phenotypic activation of mouse pulmonary macrophages.
Journal: Cellular immunology
Published: December 01, 2017
Corrigendum: Synaptic NMDA receptor activity is coupled to the transcriptional control of the glutathione system.
Journal: Nature communications
Published: September 12, 2017
Activating transcription factor 3 promotes loss of the acinar cell phenotype in response to cerulein-induced pancreatitis in mice.
Journal: Molecular biology of the cell
Published: April 20, 2017
Role of Spinophilin in Group I Metabotropic Glutamate Receptor Endocytosis, Signaling, and Synaptic Plasticity.
Journal: The Journal of biological chemistry
Published: February 17, 2016
Microglia-derived IL-1β triggers p53-mediated cell cycle arrest and apoptosis in neural precursor cells.
Journal: Cell death & disease
Published: February 19, 2015
Synaptic NMDA receptor activity is coupled to the transcriptional control of the glutathione system.
Synaptic NMDA receptor activity is coupled to the transcriptional control of the glutathione system.
Journal: Nature communications
Published: December 12, 2014
Metabotropic glutamate receptor 5 as a potential therapeutic target in Huntington's disease.
Journal: Expert opinion on therapeutic targets
Published: August 15, 2014
Metabotropic glutamate receptor 5 knockout reduces cognitive impairment and pathogenesis in a mouse model of Alzheimer's disease.
Journal: Molecular brain
Published: May 09, 2014
Last Updated: 09/26/2026